Institutional

27 de July de 2017

São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending

Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.

Click on Download to access the full text of the decision.

See file

Back

Last related news

13 de March de 2026

Federal Court in Brazil invalidates chemical patent after nearly two decades of litigation

Our firm successfully represented a company operating in the offshore oil and gas sector in a lawsuit challenging the validity of a Brazilian patent … Federal Court in Brazil invalidates chemical patent after nearly two decades of litigation

Kasznar Leonardos

5 de March de 2026

Kasznar Leonardos has been ranked by Análise Advocacia Mulher 2026

We are honored to announce that four attorneys from Kasznar Leonardos have been recognized by Análise Advocacia Mulher 2026, organized by Análise Editorial! … Kasznar Leonardos has been ranked by Análise Advocacia Mulher 2026

Kasznar Leonardos

10 de February de 2026

Kasznar Leonardos was ranked in 2025 Outstanding International IP Service Teams

We are honored to announce that, for the second year in a row, we have been recognized in the “Outstanding International IP … Kasznar Leonardos was ranked in 2025 Outstanding International IP Service Teams

Kasznar Leonardos